PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 09: Articles 4001-4500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Family planning services in adolescent pregnancy prevention: the views of key informants in four countries.
  2. Family planning, work and women's economic and social autonomy in Indonesia.
  3. Family planning. [Planification familiale.]
  4. Family planning. [Planification familiale.]
  5. Family planning. [Planification familiale.]
  6. Family planning: a new field of endeavor, a new concept. [Familienplanung: ein neuer Tatigkeitsbereich, ein neues Konzept.]
  7. Family-planning restrictions written into US law.
  8. Female adolescents at the crossroads: sexuality, contraception and abortion in Mexico.
  9. Fertility regulation by emergency contraception.
  10. Fertility, gender and war: the "culture of contraception" in Zimbabwe, 1957-1980 [abstract]
  11. Fertility, nuptiality, and family planning in Russia: problems and prospects.
  12. Flexible working in family planning and reproductive health care [editorial]
  13. Follow up on ICPD and meet challenge of new century. An interview with Zhang Weiqing, Minister of the State Family Planning Commission.
  14. Forearm bone density in users of Depo-Provera as a contraceptive method.
  15. From abortion to contraception. A resource to public policies and reproductive behavior in Central and Eastern Europe from 1917 to the present.
  16. From family planning to reproductive health: challenges facing India.
  17. From family planning to reproductive health: role of ISSRF.
  18. From secret to shelf: how collaboration is bringing emergency contraception to women.
  19. From the Clinical Effectiveness Committee. Use of rifampicin and contraceptive steroids.
  20. From the prescription of Contraceptives to their use. A study of continuity of use of contraceptive methods in migrant populations use during the postpartum period. [De la prescription contraceptive a son application. Etude de la continuite des methodes contraceptives en milieu migrant en periode post-natale.]
  21. Gender bias: the basis of unmet needs in family planning, Nongphaya village, Vientiane, Lao PDR.
  22. Gender preference contraceptive prevalence: evidence of regional variations.
  23. The GRMA / PRIME Self-Directed Learning / Client-Provider Interaction Adolescent Reproductive Health Initiative: a programme in six modules. Module 5: Family planning, emergency contraception and postabortion care services to adolescents.
  24. Guidance for implementing the "Tiahrt" requirements for voluntary family planning projects.
  25. GyneFIX. The frameless intrauterine contraceptive implant -- an update for interval, emergency and postabortal contraception.
  26. Haiti Family Planning and AIDS Prevention Survey, 1998.
  27. Health care provider communicator style and patient comprehension of oral contraceptive use [abstract]
  28. Hemostatic effects of smoking and oral contraceptive use.
  29. Historic meeting on "The Right to Family Planning, Contraception and Abortion in Ten World Religions" set for July in Philadelphia.
  30. Hormonal contraception and post-menopausal hormonal therapy.
  31. Hormonal contraception, IUDs, and HIV risk.
  32. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
  33. How does Congress approach population and family planning issues. Results of qualitative interviews with legislative directors.
  34. Husband and wife agreement, contraceptive use, and ethnicity in Nigeria.
  35. Ideation and contraceptive behavior: the relationship observed in five countries.
  36. Immediate recall of oral contraceptive instructions: implications for providers.
  37. Impact of antenatal counselling on couples' knowledge and practice of contraception in Mansoura, Egypt. [Impact de la consultation prénatale sur les connaissances et pratiques des couples en matière de contraception à Mansoura, Egypte.]
  38. The impact of family planning on women's lives: findings from the Women's Studies Project in Mali and Zimbabwe.
  39. Impact of family planning programme on socio-economic sectors in Bangladesh.
  40. The impact of family planning service provision on contraceptive-use dynamics in Morocco.
  41. The impact of family planning supply factors on unmet need in rural Egypt, 1988-1989.
  42. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.
  43. Impact of hormonal contraceptives on bone density: a cross sectional controlled study.
  44. The impact of partner-to-partner communication on reproductive health and family planning.
  45. The impact of the family planning supply environment on contraceptive intentions and use in Morocco.
  46. Implementation of state family planning programmes in a northern Chinese village.
  47. Implications for family planning of post-welfare reform insurance trends.
  48. The importance of field-workers in Bangladesh's family planning programme.
  49. Importance of levonorgestrel dose in oral contraceptives for effects on coagulation.
  50. Improving access to emergency contraceptive pills.
  51. Improving family planning program performance through management training: the 3Cs paradigm.
  52. Improving methods of emergency contraception.
  53. Improving the quality and availability of family planning and reproductive health services at the primary care level: institutional capacity building in the El Salvador Ministry of Health (MOH) [Mejoramiento de la calidad y disponibilidad de la planificación familiar y los servicios de salud reproductiva a nivel de la atención primaria: desarrollo de la capacidad institucional en el Ministerio de Salud de El Salvador.]
  54. Improving the treatment of incomplete abortion and postabortion family planning in Peru.
  55. Indonesia. Final report: Impact of ITP / OSTs in Indonesia on Bangladesh family planning programs, Sushil Ranjan Howlader. Fixed price with reimbursables contract, December 1, 1996 -May 15, 1997. AS-INO-08.
  56. Indonesia: faith and family planning.
  57. Induced abortion and prevalence of sexually transmitted diseases and contraceptive behavior in abortion cases, Gambella Hospital, south west Ethiopia.
  58. Induced abortion: a method for birth control?
  59. The influences of cognitive development and reference groups on teen contraceptive use [abstract]
  60. Informed choice in international family planning service delivery. Strategies for the 21st century. Report of a Global Working Group Meeting held at the Rockefeller Foundation, Bellagio Study and Conference Center, Bellagio, Italy, November 18-24, 1998.
  61. Informed consent for family planning for poor women in Chiapas, Mexico. [Autorización por escrito para la planificación familiar para mujeres indigentes en Chiapas, México.]
  62. Informed policy making for the prevention of unwanted pregnancy. Understanding low-income women's experiences with family planning.
  63. Injectable contraceptives: an additional choice for fertility regulation.
  64. Integrating modern family planning services into an ethnic health market in northern India.
  65. Integrating STI management into family planning services: what are the benefits?
  66. Integration of family planning with community-based health care.
  67. Inter-spousal communication on family planning as a determinant of the use of modern contraception in Bangladesh.
  68. Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: a literature review.
  69. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.
  70. International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms.
  71. International training programme for family planning / reproductive health. Invitation and guide.
  72. Interventions to promote local-level planning and coordination of essential health and family planning services: a review.
  73. Intrauterine devices. The optimal long-term contraceptive method?
  74. Introducing emergency contraceptive pill services at family planning clinics in Philadelphia: the organizational and social context. Report.
  75. Involving men in reproductive health and contraception.
  76. Iran's revolutionary approach to family planning.
  77. Islam, its leaders, play progressive role in family planning, says United Nations laureate.
  78. Issues in the financing of family planning services in sub-Saharan Africa: policy action checklist.
  79. Jamaica family planning service delivery guidelines.
  80. Jamaica Reproductive Health Survey, 1997. Young adult report: Sexual behavior and contraceptive use among young adults.
  81. Japan approves oral contraceptives.
  82. Key policies emerging to govern delivery of family planning in Medicaid managed care.
  83. Knowledge and practice of emergency contraception among Nigerian youths.
  84. Knowledge and use of birth control methods in active duty Army enlisted medical trainees.
  85. Knowledge of emergency contraception amongst female patients attending a department of genitourinary medicine.
  86. Knowledge of likely time of ovulation and contraceptive use in unintended pregnancies.
  87. Knowledge on lactational amenorrhoea and contraception in Kocaeli, Turkey.
  88. Knowledge, attitudes, and practices regarding emergency contraception among nurses and nursing students in two hospitals in Nairobi, Kenya.
  89. Lea's Shield contraceptive device: pilot study of its short-term patient acceptability and aspects of use.
  90. Lessons from community-based distribution of family planning in Africa.
  91. Levonorgestrel is a better emergency contraceptive than the combination pill.
  92. Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception.
  93. Liability concerns in contraceptive research and development.
  94. Liberia's family planning and fertility regulation policy: a re-assessment.
  95. Linking men to family planning services.
  96. Long acting female contraception: injectables and implants. Debate.
  97. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.
  98. The looming crisis in family planning and reproductive health in sub-Saharan Africa.
  99. Low dose oral contraceptives and quality of life.
  100. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
  101. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.
  102. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
  103. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
  104. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
  105. Male Contraception: Planning for the Future. Report of a symposium held May 12-13, 1999, London, England.
  106. Male contraceptive research steps back into spotlight.
  107. Male contraceptive.
  108. Male factors in family planning and contraception in Kenya: the case of Kaptumo location, Nandi district.
  109. Male fertility, contraceptive use and fertility preference in Ghana.
  110. Male involvement in family planning in Bangladesh.
  111. Management of uterine fibroids. Contraception, hormone replacement therapy, and myomas. [Prise en charge des fibromes uterins. Contraception, THS et myomes.]
  112. Managing the birth interval: women, men and Western contraception in rural Gambia.
  113. Marriage structure and contraception in Niger.
  114. Measure aiming to expand family planning introduced in Congress.
  115. Measuring contraceptive use patterns among teenage and adult women.
  116. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices.
  117. Medicolegal file. Tell everything you know about birth control pills.
  118. Men's attitudes towards family planning: a pilot study in two communes of northern Vietnam.
  119. Men's perspectives on fertility, sexuality, contraception, sexually transmitted diseases and AIDS in Ekiti, southwest Nigeria.
  120. Menstrual changes among women using hormonal contraception in Dakahlia governorate.
  121. Menstruation requirements as a barrier to contraceptive access in Kenya.
  122. Method of choice: finding the right birth control means studying the options and studying your lifestyle.
  123. Military physician and advanced practice nurses' knowledge and use of modern natural family planning [abstract]
  124. MIS promotes contraception and reproductive health: Yandu, Jiangsu.
  125. Mobility of women and access to health and family planning services in Pakistan.
  126. Monitoring and evaluation indicators reported by cooperating agencies in the Family Planning Services and Communication, Management and Training Divisions of the USAID Office of Population.
  127. Mortality of women using contraceptives. [Mortalite chez les femmes utilisant une contraception.]
  128. Most U.S. couples who seek surgical sterilization do so for contraception; fewer than 25% desire reversal.
  129. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 micrograms levonorgestrel with 20 micrograms ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
  130. National family planning program norms. [Normas del programa nacional de planificación familiar.]
  131. National strategies for women's health and family planning.
  132. Natural family planning use: an informed choice?
  133. Nepal survey shows that "family planning saves lives".
  134. New advances in emergency contraception.
  135. New awareness campaign increases appeal of family planning.
  136. New contraceptive for men.
  137. A new model for collaboration -- making emergency contraceptives available in developing countries.
  138. New Zealand's contraceptive revolutions.
  139. Non-invasive screening of teenagers for Chlamydia trachomatis in a family planning setting.
  140. Non-use, disadoption, adoption and long-term use of family planning behaviors: the case of the 1993 Philippine National Communication Campaign on Family Planning [abstract]
  141. Not just a statistic: the history of USA and UK policy over thrombotic disease and the oral contraceptive pill, 1960s-1970s.
  142. Not using contraception among women requesting abortion. [Manglende prevensjonsbruk blant abortsokende kvinner.]
  143. Nurse-midwives bolster family planning in Africa.
  144. Nurses' contraceptive advice launched for sexual health week.
  145. Objections, confusion among pharmacists threaten access to emergency contraception.
  146. Ocular complications of sex hormone preparations (oral contraception and post-menopausal hormone replacement therapy) [Complications oculaires des traitements hormonaux: contraception orale et traitement hormonal substitutif de la menopause.]
  147. On contraception and abortion in Armenia [letter]
  148. On the acceptability of different methods of family planning in Bhutan, 1986-1997.
  149. On the efficiency of multiple media family planning promotion campaigns.
  150. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt.
  151. An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol.
  152. Operations research on the female village-based family planning worker program of Pakistan.
  153. Opinions in pediatric and adolescent gynecology. Emergency contraception: for and against.
  154. Oral contraception: current use and attitudes.
  155. Oral contraception: safety issues re-examined.
  156. Oral contraceptive health benefits: perception versus reality.
  157. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.
  158. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
  159. Oral contraceptive use and risk of endometriosis.
  160. Oral contraceptive use and risk of gestational trophoblastic tumors.
  161. Oral contraceptive use associated with myocardial infarction and ischemic stroke but not angina. Research digest.
  162. Oral contraceptive use: implications for cognitive and emotional functioning.
  163. Oral contraceptive use: the application of the transtheoretical model [abstract]
  164. Oral contraceptives and compliance: reaction to cardiovascular alarm among users.
  165. Oral contraceptives and hereditary ovarian cancer [letter]
  166. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism [editorial]
  167. Oral contraceptives and smoking, current considerations: recommendations of a consensus panel.
  168. Oral contraceptives and smoking: current considerations. Introduction.
  169. Oral contraceptives and smoking: current considerations. Proceedings of a women's health consensus conference, Montreal, Canada, November 7-9, 1997. Introduction.
  170. Oral contraceptives and thrombosis. From risk estimates to health impact.
  171. Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK MediPlus Database.
  172. Oral contraceptives and women's health in Japan.
  173. Oral contraceptives, the liberator, 1956.
  174. Oral contraceptives: therapeutic uses and quality-of-life benefits -- case presentations.
  175. Oral-contraceptive use and risk of hip fracture: a case-control study.
  176. Pakistan: contraceptive prevalence rate up.
  177. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension)
  178. Patterns of contraception in UK women with Type 1 diabetes mellitus: a GP database study.
  179. The persistence of outmoded contraceptive regimes: the cases of Mexico and Brazil.
  180. Personal hormone monitoring for contraception.
  181. Pharmacists' concerns and perceived benefits from the deregulation of hormonal emergency contraception (HEC)
  182. Philippines colour-code family planning.
  183. Physicians' knowledge and practices regarding natural family planning.
  184. The "pill scare": the responses of authorities, doctors and patients using oral contraception.
  185. Pills remain the top choice among reversible contraceptive options.
  186. A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for less than or equal to 4 years.
  187. Place of oral contraceptives in India.
  188. Policies related to family planning. [Politicas relacionadas con la planificacion familiar.]
  189. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.
  190. Population growth and coercive controls: case of injectable contraceptives.
  191. Post-partum sexual abstinence in West Africa: implications for AIDS-control and family planning programmes.
  192. Postabortion family planning training launched in Zimbabwe.
  193. Predicting Neisseria gonorrhoeae and Chlamydia trachomatis infection using risk scores, physical examination, microscopy, and leukocyte esterase urine dipsticks among asymptomatic women attending a family planning clinic in Kenya.
  194. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.
  195. Pregnancies averted among U.S. teenagers by the use of contraceptives.
  196. Pregnancy prevention using emergency contraception: efficacy, attitudes, and limitations to use.
  197. Preliminary communication -- does hormonal contraception increase the risk of postnatal psychosis? [letter]
  198. Preparing for new male contraceptives.

     

  199. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
  200. Prevalence of Candida in the vaginal flora of women attended at a family planning service. [Prevalência de Cândida na flora vaginal de mulheres atendidas num serviço de planejamento familiar.]
  201. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors.
  202. Prevalence of reproductive tract infections in family planning clients in Trabzon, Turkey.
  203. Prevalence of sexual dysfunction in women seeking services at family planning centers in Tehran.
  204. Preventing repeat adolescent pregnancies with early adoption of the contraceptive implant.
  205. Probability of contraceptive continuation and its determinants. [Probabilité de la continuation de la contraception et ses déterminants.]
  206. Profile of women with an unmet need for family planning from a child survival perspective.
  207. Profiles for family planning and reproductive health programs: 116 countries.
  208. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
  209. Project: a community partnership's effort to increase youth access to contraceptives. Sponsor: Kansas Youth Foundation.
  210. The promise of public / private sector collaboration in the development of new contraceptives: the experience of CICCR.
  211. Prophylactic contraceptives for HIV / AIDS.
  212. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
  213. Prospective study of barrier contraception for the prevention of sexually transmitted diseases. Study design and general characteristics of the study group.
  214. A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy.
  215. Prospects of hormonal contraceptives for men.
  216. Provider attitudes toward dispensing emergency contraception in Michigan's Title X programs.
  217. Provision of family planning services in SNNPR.
  218. Pseudocyesis in an adolescent using the long-acting contraceptive Depo-Provera.
  219. Psychosocial correlates of contraceptive practices during late adolescence.
  220. Public / private-sector collaboration in contraceptive research and development: summary and historical perspective.
  221. Public- and private-sector partnerships in contraceptive research and development: guiding principles.
  222. Puerto Rico: contraceptive use is high, sterilization is the most popular method.
  223. Purchasing nonprescription contraceptives: the underlying structure of a multi-item scale.
  224. A qualitative study of clandestine contraceptive use in urban Mali.
  225. Quality assessment study of the family planning Service Delivery Expansion Support project in Indonesia, Jakarta, 1999.
  226. Quality of care in the delivery of family planning services in Ethiopia: Family Guidance Association of Ethiopia baseline assessment, 1997.
  227. The quality of contraception services in El Alto, Bolivia. [Calidad de los servicios de anticoncepcion en El Alto, Bolivia.]
  228. Quality, accessibility, and contraceptive use in rural Tanzania.
  229. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
  230. Reading skills and family planning knowledge and practices in a low-income managed-care population.
  231. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
  232. Reasons for discontinuing and not intending to use contraception in India.
  233. Reasons for non-acceptance of contraceptive methods among Jhuggi-Jhompri dwellers of Delhi.
  234. The recent saga of cardiovascular disease and safety of oral contraceptives.
  235. Red cell deformability in oral contraceptive pill users with sickle cell anaemia.
  236. Reducing facility defaulting and contraceptive discontinuation: a longitudinal study of facility defaulters in Ghana: key findings.
  237. Regional profile of family planning services in West Africa. A comparison of 4 situation analysis studies. [Profil regional des services de PF en Afrique de l'Ouest: une comparaison de 4 etudes d'analyse situationnelle.]
  238. Regular checkups for family planning services.
  239. The relevance of ethnic monitoring in the experience of Haringey Healthcare NHS Trust community family planning clinics.
  240. Religion-specific differentials in fertility and family planning.
  241. Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
  242. Report from the Faculty of Family Planning and Reproductive Healthcare Annual Conference, 13-14 May 1999. Orgenon Laboratories prize for the best poster. The "Safe and Sound" campaign -- a media mix approach to sex education.
  243. Reproductive choices in 2000: the relative safety of current oral contraceptives. Preface.
  244. Reproductive health through community involvement with special attention to adolescents and clinical contraception. RAS/98/P63.
  245. Reproductive issues in HIV-seropositive women: a survey regarding counseling, contraception, safer sex, and pregnancy choices.
  246. Reproductive tract infections and family planning.
  247. Research results. Decision making on the use of contraceptives.
  248. Research results. Medical barriers to contraception choice.
  249. Research results. Natural family planning (NFP): uncertain status.
  250. Reversing the downward trend in men's share of contraceptive use.
  251. Review of family planning studies and use of their results, Morocco. [Revue d'etudes en planification familiale et utilisation de leurs resultats, Maroc.]
  252. Review of newer contraceptive agents.
  253. Review of the results of the multi-country field test of quality of care indicators in clinic-based family planning programs. Minutes from meeting, April 23, 1999, Arlington, VA.
  254. Risk of HIV infection in oral contraceptive pill users: a meta-analysis.
  255. Risk of stroke in users of oral contraceptives.
  256. The risk of venous thromboembolism in users of postcoital contraceptive pills.
  257. Risk of venous thromboembolism with third-generation oral contraceptives: a review.
  258. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias.
  259. Robbing family planning to fund child survival: undermining women and children.
  260. The role of China's family planning policies in the course of fertility transition.
  261. Role of community leaders in propagating family planning messages in a Muslim community of Malegaon city, Maharashtra.
  262. The role of gender, sensitisation in the family planning program of Kenya.
  263. The role of matching menstrual data with hormonal measurements in evaluating effectiveness of postcoital contraception.
  264. Role of private sector in family planning service delivery.
  265. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
  266. The role of selective prescribing in the increased risk of VTE associated with third-generation oral contraceptives.
  267. Safer sex at holiday centres: providing contraceptive services to seasonal workers.
  268. The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 micrograms and ethinylestradiol 15 micrograms.
  269. Safety of modern oral contraception: the options for women: lessons to be learned.
  270. Screening for activated protein C resistance before oral contraceptive treatment: a pilot study.
  271. Secret use of contraceptives.
  272. Service Delivery Expansion Support (SDES) Project: expanding family planning services in Indonesia. Report of achievements, 1994-1997.
  273. Sex, contraception and childbearing among high-risk youth: do different factors influence males and females?
  274. Sexual behavior and condom use among urban women attending a family planning clinic in the United States.
  275. Sexual behavior, contraception, and risk among college students.
  276. Sexual lifestyle and use of contraceptives among graduating female university students: implication for sexuality education.
  277. Sexuality, contraception and abortion among unmarried adolescents and young adults: the case of Korea.
  278. Should eliminating unmet need for contraception continue to be a program priority?
  279. Should emergency contraceptive pills be available without prescription? [Comment]
  280. Should management of sexually transmitted infections be integrated into family planning services: evidence and challenges.
  281. Sixteen to nineteen year olds' use of, and beliefs about, contraceptive services.
  282. Small area estimation methods with application to contraceptive prevalence rates in Bangladesh.
  283. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ.
  284. Smoking and use of oral contraceptives: impact on thrombotic diseases.
  285. Something new for the East: On the sense of integrating medical family planning counseling and provision into a comprehensive counseling package. [Fur den Osten was Neues. Uber den Sinn der Integration arztlicher Familienplanungsberatung und -versorgung in ein umfassendes Beratungsangebot.]
  286. Southern Africans to blend emergency contraception into regular health care services.
  287. Sports, sexual behavior, contraceptive use, and pregnancy among female and male high school students: testing cultural resource theory.
  288. State contraceptive coverage laws: creative responses to questions of "conscience".
  289. State efforts to expand Medicaid-funded family planning show promise.
  290. Statistical evidence about the mechanism of action of the Yuzpe regimen of emergency contraception.
  291. Status of problems with administration of hormonal contraceptives. [Problemsituationen unter der Einnahme hormonaler Kontrazeptiva.]
  292. STD / AIDS prevention in family planning programs.
  293. The story of CARE's successful integration of family planning and reproductive health services: a case study.
  294. Strategies for improving the quality and performance of clinical contraceptive services.
  295. Striae distensae of augmented breasts after oral contraceptive therapy.
  296. Study of the effects of incorporating selected reproductive health services on family planning services: a case study in the Eastern Region of Ghana.
  297. Study on 46,000 women. Long-term effects of oral contraception: The pill is effective. [Studie an 46,000 Frauen. Langzeitfolgen der oralen Kontrazeption: Die Pille kommt gut weg.]
  298. A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: a case report.
  299. A technological revelation: an ideological examination of the technology of contraception and population control [abstract]
  300. Teenagers, young people and family planning: a survey in five Romanian high schools.
  301. Their role growing, Catholic hospitals juggle doctrine and medicine. They make "fine distinctions" on issues like abortion; consulting "the Moralist". "Off-Site" birth control service.
  302. Therapeutic controversy: the safety of third-generation oral contraceptives.
  303. There is no reason to oppose voluntarism in family planning.
  304. There's more to population issue than birth control.
  305. In three former Soviet states, rates of abortion are declining as contraceptive prevalence increases.
  306. Time for more information on postcoital contraception (letter) [Pa tide a bli kjent med nodprevensjon.]
  307. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen [letter]
  308. Title X family planning clinics confront escalating costs, increasing needs.
  309. Training module on family planning and safe motherhood. For the use of students in the 6th year of medicine. [Module de formation en planification familiale et maternité sans risque. A l'usage des étudiants en 6ème année de médecine.]
  310. The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect.
  311. Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by repeat CC treatment.
  312. Two good reasons: women's and men's perspectives on dual contraceptive use.
  313. U.S. policy can reduce cost barriers to contraception.
  314. UK accident and emergency departments and emergency contraception: what do they think and do?
  315. Unjust punishment, forced contraception, and poor treatment of women by the courts and prisons.
  316. Unmet contraceptive need in Bangladesh: evidence from the 1993/94 and 1996/97 Demographic and Health Surveys.
  317. Unmet need for family planning: a challenge for the RCH programme.
  318. Updated estimates of the efectiveness of the Yuzpe regimen of emergency contraception.
  319. USAID: raising the quality of family planning worldwide.
  320. The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives.
  321. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women.
  322. Use of oral contraceptives and uterine fibroids: results from a case-control study.
  323. Venous thromboembolic disease and combined oral contraceptives: a re-analysis of the MediPlus database.
  324. Venous thromboembolism among new users of different oral contraceptives.
  325. Venous thromboembolism and oral contraceptives [letter]
  326. Venous thromboembolism and oral contraceptives [letter]
  327. Venous thromboembolism and oral contraceptives [letter]
  328. Venous thromboembolism and oral contraceptives. Authors' reply [letter]
  329. Venous thromboembolism and the pill. The combined oral contraceptive pill -- are poor communication systems responsible for loss of confidence in this contraceptive method?
  330. Viagra speeds contraceptive pill ok in Japan.
  331. The vision and mission statement for population development and the national family planning movement.
  332. Ways to expand contraceptive choices.
  333. Weight change in adolescents who used hormonal contraception.
  334. What are emergency contraceptive pills?
  335. What are family planning clinics for? [letter]
  336. What prevents family planning clinics in developing countries from adopting a client orientation? An exploratory study from Malawi.
  337. Where did family planning come from and where is the speciality going?
  338. Where has India's family planning programme gone?
  339. Why is teenage pregnancy declining? The roles of abstinence, sexual activity and contraceptive use.
  340. Why the Pope can't change the Church's position on birth control: implications for Americans.
  341. Will the "real" mother please stand up? The logic of eugenics and American national family planning.
  342. Witness for responsible parenthood and family planning.
  343. Women's experience and satisfaction with emergency contraception.
  344. Women's experiences of obtaining emergency contraception: a phenomenological study.
  345. Women's fears and men's anxieties: the impact of family planning on gender relations in northern Ghana.
  346. Women's reproductive rights, modernization, and family planning programs in developing countries: a causal model.
  347. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.
  348. Women, fertility and family planning in Ethiopia.
  349. Women, men, and contraceptive sterilization.
  350. World contraceptive use, 1998. [Wallchart]
  351. Worldliness and fertility control: cultural attributes of contraceptive users among rural Bangladeshi women.
  352. Young males attending a family-planning clinic: some ideas about consequences of child abuse.
  353. The epidemiology of oral contraceptive use: a critical review of the studies on oral contraceptives and the health of young women.
  354. Reversible contraception: issues faced by emerging countries.
  355. Use of family planning at first sexual intercourse among young adults in Ecuador. [Utilización de la planificación familiar en la primera relación sexual entre adultos jóvenes en Ecuador.]
  356. Alternative contraceptive methods and fertility decline in India.
  357. Poverty, demographic growth, and birth control: a critique of Peter Singer's ethical perspective on the relationship between rich and poor. [La pobreza, el crecimiento demográfico y el control de la natalidad. Una critica a la perspectiva ética de Peter Singer sobre la relación entre ricos y pobres.]
  358. Covert contraceptive use: prevalence, motivations, and consequences.
  359. Strengthening the utilization of family planning operations research: findings from case studies in Africa.
  360. Linkages with treatment for incomplete abortions improve family planning services in Kenya.
  361. The Equity in Prescription Insurance and Contraceptive Coverage Act.
  362. Community health training empowers women: a case study of the Promotoras Comunitarias program of Planned Parenthood Los Angeles.
  363. Knowledge and perceptions of emergency contraception among Mexican women. Final report. [Conocimientos y percepciones sobre la anticoncepción de emergencia en las mujeres mexicanas. Informe final.]
  364. Comprehensive reproductive health and family planning training curriculum. Module 13: Postpartum and postabortion contraception.
  365. Comprehensive reproductive health and family planning training curriculum. Module 3: Counseling for family planning services.
  366. Emergency contraception questions and answers for clinical providers.
  367. Emergency contraception questions and answers for non-clinical providers.
  368. Contraception.
  369. Contraceptives: nonoxynol-9 protects against HIV transmission.
  370. Vietnam: changing family planning policies.
  371. Philippines communication outreach accelerates family planning use in 1993-1996.
  372. Contraception among limiters and spacers in Matlab, Bangladesh.

     

  373. Genuineness of statistics on reversible methods of family planning: a field investigation in rural Karnataka.
  374. Social change and family planning: a study of backward classes.
  375. The feminist debate on reproductive rights and contraception in Bangladesh.
  376. Family planning and the reproductive rights of women.
  377. The role of the provider in family planning and reproductive health services marketing: lessons learned from SOMARC III.
  378. The gestation of change: family planning innovations in Uganda. Using new social marketing methods to reach unserved and underserved populations.
  379. Pocketbook of family planning and reproductive health indicators for program design and evaluation.
  380. Economic and psychosocial influences of family planning on the lives of women in Western Visayas: final report.
  381. Egypt. The role of women as family planning employees.
  382. Egypt: the impact of family planning on the lives of Egyptian women.
  383. Mali. Impact of family planning on the lives of new contraceptive users in Bamako.
  384. Bangladesh: family planning and women's empowerment.
  385. Bolivia. Follow-up to the 1994 DHS: women's economic activities, fertility and contraceptive use.
  386. Contraceptive update: Experimental male methods inhibit sperm.
  387. Indonesia: family planning and women's empowerment in the family.
  388. Indonesia: family planning, family welfare and women's activities.
  389. Indonesia: family planning, women's work and women's household autonomy.
  390. Malaysia. The effects of family planning on marital disruption in Malaysia.
  391. Philippines. Family planning: its economic and psychosocial influences on the lives of women in Western Visayas.
  392. Philippines. Social and economic consequences of family planning use in the southern Philippines.
  393. Women's voices, women's lives: the impact of family planning. A synthesis of findings from the Women's Studies Project, Family Health International.
  394. Zimbabwe. The impact of family planning on women's participation in the development process.
  395. Zimbabwe: consequences of family planning for women's quality of life.
  396. Capacity building approach in health and family planning in Bangladesh. The CHILD II Project: a USAID centrally-funded program (FAO-0500-A-00-5035-00)
  397. Poverty and contraceptive use in rural Mexico. [Pobreza y uso de anticonceptivos en zonas rurales de México.]
  398. Poverty, family planning and fertility vis-a-vis management of family planning services in India. A case study.
  399. Report on seminar: "Poverty, Fertility and Family Planning". Seminar held in Mexico City, June 2-4, 1998. [Informe sobre el seminario: "Pobreza, fertilidad y planificación familiar". Seminario llevado a cabo en la ciudad de México, del 2 al 4 de junio de 1998.]
  400. How to improve family planning and save lives using a stage-of-life approach.
  401. The quality of family planning services for breastfeeding women in Senegal.
  402. Teenage contraceptive needs in urban South Africa: a case study.
  403. The challenge of contraceptive implant removals in East Nusa Tenggara, Indonesia.
  404. Family planning clinics through women's eyes and voices: a case study from rural Bangladesh.
  405. Patterns of desired fertility and contraceptive use in Kuwait.
  406. Increasing access to family planning services in rural Mali through community-based distribution.
  407. Couples' fertility and contraceptive decision-making in developing countries: hearing the man's voice.
  408. Informed choice and decision-making in family planning counseling in Kenya.
  409. Improving contraceptive access for teens.
  410. Adolescent oral contraceptive use: factors predicting compliance at 3 and 12 months.
  411. Family planning programs: improving quality./Programas de planejamento familiar: melhoria da qualidade./Programmes de planification familiale : ameliorer la qualite./Programas de planificacion familiar: mejorias en la calidad. [Programas de Planejamento Familiar: Melhoria da qualidade.]
  412. The effects of postnatal health education for mothers on infant care and family planning practices in Nepal: a randomised controlled trial.
  413. Management of sickle cell disease. Contraception with medroxyprogesterone may be beneficial [letter]
  414. Medical Devices Agency wants to see prospective clinical study of contraceptive device [letter]
  415. Family planning clinic opens in UK pharmacy.
  416. Indian women's groups question contraceptive vaccine research.
  417. Bangladesh's experiences with human resource development strategies in family planning service delivery: a critical look at the past and directions for the future.
  418. Risks of oral contraceptives [letter]
  419. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
  420. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
  421. The role of Gardnerella vaginalis in nonspecfic vaginitis in intra uterine contraceptive device users.
  422. The role of men in family planning in Imo State of Nigeria.
  423. The role of men in family planning in Kogi State of Nigeria.
  424. The role of men in family planning in Kwara State of Nigeria.
  425. The role of men in family planning in Niger State, Nigeria.
  426. The role of men in family planning in Nigeria: a case study of Cross River State.
  427. The role of men in family planning in Nigeria: a case study of Edo State.
  428. Role of men in family planning in Ondo State of Nigeria.
  429. The role of men in family planning in Oyo State, Nigeria.
  430. Role of Muslim leaders and organizations in Indonesian national family planning / reproductive health program.
  431. Roundtable: "If men's erections are going to be funded, why are women still paying for birth control?"
  432. Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism.
  433. Safety of emergency contraception.
  434. A scenario study of oral contraceptive use in Japan. Toward fewer unintended pregnancies.
  435. Screening for pregnancy and contraceptive use among women admitted to a Denver detoxification center.
  436. Screening women for Chlamydia trachomatis in family planning clinics. The cost-effectiveness of DNA amplification assays.
  437. SEATS dissemination conference. Results of the Collaborative Family Planning and Reproductive Health Services Development Project, Vladivostok, Russia, November 3-5, 1997.
  438. SEATS. Family Planning Service Expansion and Technical Support Project. Senegal final report.
  439. SEATS. Family Planning Service Expansion and Technical Support Project. Senegal final report: annexes.
  440. Seattle pilot project makes emergency contraception available directly from pharmacists.
  441. Secrecy and silence: why women hide contraceptive use.
  442. Secrecy still surrounds contraception in Ireland.
  443. Seeking appropriate sexual and reproductive health services. Reproductive health service delivery. Adolescent Reproductive Health Project: Planned Parenthood Association of South Africa.
  444. Self-administered emergency contraception -- a second chance [editorial]
  445. Sex discrimination and insurance for contraception.
  446. Sex education and contraceptive methods: knowledge and sources of information among the Estonian population.
  447. Sex ratio associated with timing of insemination and length of the follicular phase in planned and unplanned pregnancies during use of natural family planning.
  448. Sex, contraception and childbearing among high-risk youth: do different factors influence males and females?
  449. Sexual activity and contraceptive use: the components of the decisionmaking process.
  450. Sexual and physical abuse among incarcerated youth: implications for sexual behavior, contraceptive use, and teenage pregnancy.
  451. Sexual awareness: contraception, sexual behaviors and sexual attitudes.
  452. Sexual behavior and contraceptive knowledge and use among adolescents in developing countries.
  453. Sexuality and contraception among Nigerian adolescents and youth.
  454. Sexually transmitted diseases and reproductive tract infections among contraceptive users.
  455. The dynamics of the Morocco family planning program. Key findings of evaluation research, 1992-1997. [La dynamique du programme de planification familiale du Maroc. Resultats-cles de la recherche d'evaluation 1992-1997.]
  456. Education as policy: the impact of education on marriage, contraception, and fertility in Colombia, Peru, and Bolivia.
  457. The effect of a family planning CBD project in Mali.
  458. The effect of changing sexual, marital and contraceptive behaviour on conceptions, abortions, and births.
  459. Effect of desogestrel-containing oral contraceptives on vascular reactivity and catecholamine levels.
  460. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial.
  461. The effect of family planning on women's lives: the case of the People's Republic of China.
  462. The effect of family planning programs on the fertility of welfare recipients. Evidence from Medicaid claims.
  463. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
  464. Effect of oral contraceptive progestins on serum copper concentration.
  465. The effect of oral contraceptive use on the prognosis of node positive breast cancer patients.
  466. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
  467. Effect of the British warning on contraceptive use in the General Medical Service in Ireland.
  468. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
  469. The effect of women's status on contraceptive use in rural Bangladesh. Draft.
  470. Effectiveness and cost-effectiveness of family planning in the Philippines.
  471. Effects of contraceptives on hemoglobin and ferritin.
  472. Effects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activity.
  473. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise.
  474. Effects of oral contraceptives containing different progestogens on sodium-lithium countertransport in normal females.
  475. Effects of oral contraceptives on free fatty acid metabolism in women.
  476. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
  477. The effects of self-administering emergency contraception [letter]
  478. The effects of self-administering emergency contraception.
  479. Effects on bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a 2-year follow-up.
  480. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
  481. The effects on mortality of the use of combined oral contraceptives.
  482. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
  483. Efficacy and safety of the new antiandrogenic oral contraceptive Belara.
  484. Elevated serum prolactin level with high-dose estrogen contraceptive pills.
  485. Emergency contraception (ECP) [letter]
  486. Emergency contraception -- cost-accounting [editorial]
  487. Male fertility, contraceptive use, and reproductive preferences in Latin America: the DHS experience.
  488. Male involvement in family planning and reproductive health in Pakistan: a review of the literature.
  489. Male involvement in family planning in Turkey.
  490. Male involvement in the Bangladesh family planning and reproductive health program.
  491. Male perspectives on contraceptive methods. [Perspectiva masculina quanto a metodos contraceptivos.]
  492. Management information systems in the Indonesian family planning program.
  493. Manual for reproductive health and family planning training for nursing school faculty, Asuncion, Paraguay. [Manual para la capacitacion en salud reproductiva y planificacion familiar a profesoras(es), escuelas de enfermeria, Asuncion, Paraguay.]
  494. Marie Stopes, Eugenics and the English Birth Control Movement, edited by Robert A. Peel. [Book review]
  495. Masculine perceptions of family planning and reproductive health needs and services: a qualitative study in Chimbote. [Percepciones masculinas de las necesidades y servicios de planificacion familiar y salud reproductiva: un estudio cualitativo en Chimbote.]
  496. Measuring changes in family planning services quality over time.
  497. Measuring true contraceptive efficacy. A randomized approach -- condom vs. spermicide vs. no method.
  498. Meeting family planning needs in Mongolia.
  499. Meeting the unmet need for family planning in East Nusa Tenggara.
  500. Men and family planning in Morocco. From the viewpoint of the "forgotten ones". Focus group research in the greater Casablanca, Marrakech / Tensift, and Meknes / Tafilalet regions. [Les hommes et la planification familiale au Maroc. Du cote des "oublies". Recherche par focus group dans les regions du Grand Casablanca, Marrakech / Tensift, et Meknes / Tafilalet.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later ver